As the 2024–2025 respiratory syncytial virus (RSV) season is coming to an end, healthcare systems are reflecting on the lessons learned from this year’s patient data. Seasonal respiratory infections, including RSV, influenza, COVID-19, and other respiratory viruses, continue to place a significant strain on hospitals.
At LOGEX, we are addressing this challenge with our Infectious Disease Observatory, a data-driven initiative designed to generate insights into relevant healthcare outcomes for hospitalised patients and, in turn, support informed decision-making for stakeholders in hospitals and pharmaceutical companies.
The Infectious Disease Observatory: A Multi-Stakeholder Approach
Our Infectious Disease Observatory operates across multiple countries, engaging key stakeholders in healthcare and life sciences. By integrating direct hospital data with external sources such as claims and laboratory data, we generate real-time insights into respiratory tract infections. This approach allows us to distinguish between different pathogens causing lower respiratory tract infections, providing a clearer picture of the true impact of RSV on healthcare systems.
What Insights Are We Generating?
By linking different hospital datasets across multiple sources, we provide:
- Visibility into patient characteristics: Understanding who is hospitalised with RSV and how these patients differ from those with, for example, influenza or COVID-19.
- Pathogen-specific outcomes: Healthcare providers can track outcomes for different infections, helping them optimise patient care strategies.
- Hospital benchmarking: Comparing healthcare resource utilisation (HCRU) between hospitals, enabling best-practice sharing and efficiency improvements.
- Seasonal and post-COVID shifts: Understanding how respiratory infection patterns are evolving, which is critical for potential future pandemic preparedness.
Why This Matters for Healthcare
Every respiratory virus season puts healthcare systems under pressure, making effective planning essential. Our Infectious Disease Observatory gathers real-world data to help healthcare providers prepare for future outbreaks, optimise treatment pathways, and allocate resources efficiently. By distinguishing RSV from other respiratory viruses like influenza and COVID-19, we enable better patient care and hospital management. Our insights may also support the evaluation of new vaccines, immunisations, and antiviral treatments, helping healthcare systems stay ahead of emerging challenges.
Join the Infectious Disease Observatory now for the Next Season
The work continues beyond this season! We are actively expanding the Infectious Disease Observatory and inviting both hospitals and life science companies to join. Hospitals can participate for free and gain valuable data-driven insights to improve patient care and operational efficiency.
If your organisation is interested in contributing to a smarter, more prepared healthcare system, get in touch with us today!